The Infection Control Today® COVID-19 page brings readers the latest information and clinical updates on the coronavirus disease 2019 pandemic, from case counts and hospitalization rates to data on effective treatments for severe disease and the circulating viral variants.
July 25th 2024
Balancing personal struggles and professional responsibilities during crises requires self-awareness, self-compassion, healthy boundaries, and support networks. Embrace these strategies to navigate and overcome challenges.
Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?
View More
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
LTC Facilities Face Unique Infection Control Issues During COVID-19 Pandemic
November 29th 2022Integrating home and community, long-term care facilities are supposed to be a haven for patients and their families. But during the COVID-19 pandemic, keeping the patients and the staff safe was a constant battle. An infection preventionist who lived through it discusses the challenges at her facility.
Developing Vaccines to Fight Sepsis Caused by ExPEC and S. aureus
November 11th 2022Extra-intestinal pathogenic Escherichia coli (ExPEC) and Staphylococcus aureus (S. aureus) are 2 of the leading causes of severe sepsis, and Janssen Pharmaceutical Companies of Johnson & Johnson is developing vaccines to fight those diseases.
Respiratory Spread and the Flawed Concept of Immunological Debt: A New Understanding
November 8th 2022CDC discusses potential proposals to redefine spread and to produce uniform guidelines across different types of facilities because public health interventions do not cause immunological debt but instead may prevent immunocompromising infections.
Is the Current Bivalent Booster the Correct One? Studies Suggest it Isn't
November 1st 2022Despite study results that the univalent BA.5 booster produced much higher increase in antibodies, why was the hybrid bivalent Ancestral/BA.5 booster with a significantly lower increase chosen to be distributed, and how does this put the population at risk?
Temporary Isolation Wards During COVID-19 Pandemic Prove Effective Against Transmission Risk
October 28th 2022Temporary isolation wards were used continually throughout 2021, during a surge in community transmission driven by the COVID-19 Delta variant, but were the wards effective in keeping down environmental transmission?
Nurses and Infection Preventionists: An Integral Partnership
October 27th 2022Infection preventionists and perioperative nurses should collaborate to track and share infection rate data and participate in interdisciplinary workgroups to emphasize patient safety amid burnout and staffing and supply shortages.